On February 28, 2023 Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, reported that it will participate in two upcoming healthcare conferences (Press release, Alpine Immune Sciences, FEB 28, 2023, View Source [SID1234627853]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Tuesday, March 7th at 10:30am ET/7:30am PT, the Company will take part in a corporate panel discussion on autoimmune and inflammatory diseases and host investor meetings at the 46th Annual Cowen Healthcare Conference
Tuesday, March 14th at 3:20pm ET/12:20 pm PT, the Company will participate in a fireside chat and host investor meetings at the 33rd Annual Oppenheimer Healthcare Conference.
Live webcasts of the presentations will be available in the investor relations section of the Company’s website at View Source and replays will be available on the Company’s website for 90 days following the live events.